Allianz Asset Management Gmb H Hutchmed (China) LTD Transaction History

Allianz Asset Management Gmb H

$69.7 Billion
Q3 2024

A detailed history of Allianz Asset Management Gmb H transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 1,324,791 shares of HCM stock, worth $19 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,324,791

Previous 1,501,643 11.78%

Holding current value

$19 Million

Previous $25.7 Million 0.74%

% of portfolio

0.04%

Previous 0.04%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$16.03 - $20.31 $2.83 Million - $3.59 Million	-176,852 Reduced 11.78%	1,324,791 $25.9 Million
Q2 2024 Aug 13, 2024	SELL	$16.36 - $21.78 $1.04 Million - $1.39 Million	-63,715 Reduced 4.07%	1,501,643 $25.7 Million
Q1 2024 May 13, 2024	BUY	$12.08 - $18.56 $97,099 - $149,185	8,038 Added 0.52%	1,565,358 $26.3 Million
Q4 2023 Feb 12, 2024	SELL	$16.25 - $20.23 $1.42 Million - $1.77 Million	-87,679 Reduced 5.33%	1,557,320 $28.2 Million
Q3 2023 Nov 13, 2023	SELL	$11.85 - $16.95 $2.72 Million - $3.89 Million	-229,787 Reduced 12.26%	1,644,999 $27.9 Million
Q2 2023 Aug 11, 2023	SELL	$10.78 - $17.73 $2.99 Million - $4.91 Million	-277,151 Reduced 12.88%	1,874,786 $22.5 Million
Q1 2023 May 11, 2023	SELL	$13.02 - $19.87 $403,528 - $615,830	-30,993 Reduced 1.42%	2,151,937 $28 Million
Q4 2022 Feb 13, 2023	BUY	$7.65 - $15.51 $3.22 Million - $6.53 Million	421,241 Added 23.91%	2,182,930 $32.3 Million
Q3 2022 Nov 08, 2022	BUY	$8.63 - $15.52 $4.21 Million - $7.58 Million	488,185 Added 38.33%	1,761,689 $15.6 Million
Q2 2022 Aug 12, 2022	SELL	$8.59 - $20.77 $1.58 Million - $3.82 Million	-184,020 Reduced 12.63%	1,273,504 $16.1 Million
Q1 2022 May 13, 2022	SELL	$15.52 - $35.65 $1.91 Million - $4.39 Million	-123,014 Reduced 7.78%	1,457,524 $27.6 Million
Q4 2021 Feb 11, 2022	SELL	$28.89 - $35.33 $4.04 Million - $4.94 Million	-139,821 Reduced 8.13%	1,580,538 $55.4 Million
Q3 2021 Nov 10, 2021	SELL	$35.66 - $42.94 $7.49 Million - $9.03 Million	-210,178 Reduced 10.89%	1,720,359 $63 Million
Q2 2021 Aug 16, 2021	BUY	$23.7 - $39.27 $5.53 Million - $9.16 Million	233,239 Added 13.74%	1,930,537 $75.8 Million
Q1 2021 May 13, 2021	BUY	$27.01 - $36.8 $1.44 Million - $1.96 Million	53,216 Added 3.24%	1,697,298 $47.9 Million
Q4 2020 Feb 16, 2021	BUY	$27.51 - $34.36 $6.57 Million - $8.21 Million	238,840 Added 17.0%	1,644,082 $52.6 Million
Q3 2020 Nov 13, 2020	SELL	$25.8 - $34.61 $2.52 Million - $3.38 Million	-97,800 Reduced 6.51%	1,405,242 $45.4 Million
Q2 2020 Aug 14, 2020	BUY	$17.65 - $28.05 $3.97 Million - $6.32 Million	225,200 Added 17.62%	1,503,042 $41.5 Million
Q1 2020 May 14, 2020	BUY	$15.19 - $29.51 $8.29 Million - $16.1 Million	546,000 Added 74.61%	1,277,842 $22.8 Million
Q4 2019 Feb 13, 2020	SELL	$17.17 - $25.95 $182,585 - $275,952	-10,634 Reduced 1.43%	731,842 $18.3 Million
Q3 2019 Nov 13, 2019	BUY	$17.84 - $22.69 $1.21 Million - $1.53 Million	67,600 Added 10.02%	742,476 $13.2 Million
Q2 2019 Aug 08, 2019	BUY	$22.0 - $31.78 $1.58 Million - $2.28 Million	71,682 Added 11.88%	674,876 $14.8 Million
Q1 2019 May 13, 2019	BUY	$21.27 - $30.58 $3.31 Million - $4.76 Million	155,700 Added 34.79%	603,194 $18.4 Million
Q3 2018 Nov 13, 2018	BUY	$26.55 - $34.38 $3.82 Million - $4.94 Million	143,765 Added 47.33%	447,494 $14.4 Million
Q2 2018 Aug 13, 2018	BUY	$27.79 - $34.49 $1.83 Million - $2.27 Million	65,756 Added 27.63%	303,729 $9.15 Million
Q1 2018 May 14, 2018	BUY	$28.87 - $41.13 $1.81 Million - $2.58 Million	62,673 Added 35.75%	237,973 $7.03 Million
Q4 2017 Feb 13, 2018	SELL	$27.41 - $39.42 $3.4 Million - $4.88 Million	-123,900 Reduced 41.41%	175,300 $6.91 Million
Q3 2016 Apr 17, 2019	BUY	N/A	299,200	299,200 $3.56 Million

Others Institutions Holding HCM

# of Institutions

Shares Held

6.88M

Call Options Held

6.2K

Put Options Held

1.1K

View Full List

About HUTCHMED (China) Ltd

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $2.47B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

More about HCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Account

Allianz Asset Management Gmb H Hutchmed (China) LTD Transaction History